Fig. 3From: A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosisTime course of tumor markers from the first visit to the postoperative period. FCD: Fibrocystic disease, ADH: Atypical ductal hyperplasia, DCIS: Ductal carcinoma in situ, CFPN-PI: Cefcapene pivoxil, MINO: Minocycline, PSL: PrednisoloneBack to article page